Stay updated on Exemestane in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Exemestane in NSCLC Clinical Trial page.

Latest updates to the Exemestane in NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page shows a new Revision tag (v3.6.3) replacing the previous v3.6.2, indicating a backend/page version update. This appears to be a maintenance update rather than a change to the study data or user-facing details.SummaryDifference0.0%

- Check27 days agoChange DetectedThe site’s revision tag was updated from v3.6.0 to v3.6.2, signaling a small platform update. This does not modify the study details or other visible content on the page.SummaryDifference0.0%

- Check41 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', indicating the study is not enrolling anymore. New help and navigation sections have been added (How to Read a Study Record, Common Questions, How to Join a Study), the Intervention/Treatment header formatting changed, and the site revision advanced to v3.6.0.SummaryDifference0.4%

- Check49 days agoChange DetectedRevision updated to v3.5.5 on the page, replacing the previous revision v3.5.4. This reflects an internal update to the page's versioning system without altering displayed study content.SummaryDifference0.1%

- Check70 days agoChange DetectedThe sponsor attribution was updated to 'Masonic Cancer Center, University of Minnesota' instead of 'University of Minnesota Masonic Cancer Center', aligning with the institution's preferred naming. A new page revision tag 'Revision: v3.5.4' was added to indicate the latest update.SummaryDifference0.1%

- Check91 days agoChange DetectedThe page’s footer revision/version number was updated from v3.5.2 to v3.5.3, reflecting a change to the ClinicalTrials.gov site build rather than any modification to the study details.SummaryDifference0.1%

Stay in the know with updates to Exemestane in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Exemestane in NSCLC Clinical Trial page.